NOVAVAX ($NVAX) posted quarterly earnings results for Q3 2026 on Thursday, November 5th. The company reported earnings of -$0.19 per share, beating estimates of -$0.34 by $0.15. The company also reported revenue of $68,300,000, beating estimates of $51,438,895 by $16,861,105.
You can see Quiver Quantitative's $NVAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NOVAVAX Hedge Fund Activity
We have seen 106 institutional investors add shares of NOVAVAX stock to their portfolio, and 124 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA INVESTMENTS, LP added 3,476,244 shares (+565.4%) to their portfolio in Q2 2026, for an estimated $32,746,218
- BANK OF AMERICA CORP /DE/ removed 3,220,978 shares (-48.5%) from their portfolio in Q2 2026, for an estimated $30,341,612
- UBS GROUP AG removed 2,608,042 shares (-58.2%) from their portfolio in Q2 2026, for an estimated $24,567,755
- MILLENNIUM MANAGEMENT LLC removed 2,084,382 shares (-54.1%) from their portfolio in Q2 2026, for an estimated $19,634,878
- SHAH CAPITAL MANAGEMENT removed 1,992,096 shares (-14.1%) from their portfolio in Q3 2026, for an estimated $21,534,557
- GOLDMAN SACHS GROUP INC added 1,598,310 shares (+113.4%) to their portfolio in Q2 2026, for an estimated $15,056,080
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,346,607 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,685,037
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
